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ABSTRACT 
 
A class of Caenorhabditis elegans genes encodes amino acid sequence motifs 
similar to surface proteins of the parasitic nematode, T. canis, and therefore can serve as a 
model for the parasite’s nematomucin expression. Putative surface protein expression in 
C. elegans surface mutants was compared to wild-type expression using anti-peptide 
antibodies. SDS-PAGE determined protein viability and western blotting revealed protein 
expression similarities. bah-1(br1), srf-2(br3), bus-4(br4), bah-2(br7), and srf-6(yj13) 
showed a 52 kDa protein band similar to the wild-type, and bah-1(br1) expressed an 
additional 36 kDa protein.
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BACKGROUND 
 
 
Caenorhabditis elegans is Developmentally and Anatomically Similar to Other 
Nematodes 
 
As a typical nematode, the wild type Caenorhabditis elegans organism develops 
through four larval stages (L1, L2, L3, and L4) and an adult stage separated by molts 
during which the outer covering of the worm, the cuticle, is shed and replaced (Politz and 
Phillip, 1992; Riddle et al., 1997).  The population exists predominantly as self-fertilizing 
hermaphrodites, producing sperm at the L4 stage and oocytes as an adult (Riddle et al., 
1997). In conditions of crowding or food limitation, the species undergoes phenotypic 
morphogenesis at the second molt, becoming dauer larvae. Dauer larvae have no body 
openings, do not feed, and have an altered energy metabolism. This state enables the 
worm to live for months in starved conditions compared to the ~2 week lifespan of wild 
type species (Riddle et al., 1997). 
The body of nematodes is constructed of two concentric tubes. The intestine 
comprises the inner tube, whereas the nervous system, muscle layers, and cuticle make up 
the outer tube as shown in Figure 1. Due to the uniformity of development and anatomy 
of members within the phylum Nematoda, the use of one species as a model, such as the 
free-living C. elegans, would be ideal (Politz and Phillip, 1992).  With a three-day life 
cycle and Escherichia coli as a food source, thousands of C. elegans progeny are easily 
grown on a Petri dish (Riddle et al., 1997). These characteristics make the species 
favorable as a model for parasites, which have complex life cycles requiring one or more 
hosts, and therefore are much more difficult experimentally.   
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Figure 1. Posterior cross-section of an adult hermaphrodite (g- gonad, i- intestine, m- muscle, nc- nerve 
cord). Reproduced from Edwards and Wood 1983. 
 
Cuticle Composition and Synthesis 
The body of C. elegans is enclosed in an extracellular matrix termed the cuticle. 
In the adult stage of the nematode life, six layers of the cuticle are present: the epicuticle, 
external and internal cortical, medial, a honeycomb fibrous layer, and basal layers 
(Kramer, 1997; Peixoto et al., 1997). Synthesized by the hypodermal cells, a new cuticle 
is produced at four periods called molts during postembryonic development such that, 
with each new molt, the new cuticle is synthesized below the previous (Page & 
Johnstone, 2007). Expression of more than 170 cuticle collagen genes also varies with 
each developmental stage (Peixoto et al., 1997; Page & Johnstone, 2007). Only the adult, 
dauer, and L1 stage cuticles are distinct from one another, whereas the L2-L4 cuticles 
have similar fibrous layers (Kramer, 1997). 
Although the cuticle is primarily collagen, it contains other proteins, such as 
insoluble cuticlin and surface glycoproteins (Peixoto et al. 1997). Cuticular collagens 
encoded by different C. elegans collagen genes are similar in that they have an N-
terminal non Gly-X-Y amino domain, a central Gly-X-Y domain, and a C-terminal non 
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Gly-X-Y domain which is variable in length (see Figure 2). X is commonly proline and Y 
is commonly hydroxyproline (Kramer 1997; Page & Johnstone, 2007).  
 
 
 
 
Figure 2. Domains of a cuticular collagen. Adapted from Page & Johnstone, 2007. 
Above the epicuticle of nematodes is the negatively charged surface coat, which 
contains mucin-like glycoproteins and is 5-20nm thick (Blaxter and Bird, 1997). Mucins 
are O-glycosylated glycoproteins with many serine and threonine residues in the 
polypeptide moiety (Varki et al., 1999). They may be cell surface associated or secreted. 
In Toxocara canis, the surface coat has been shown to contain O-linked glycans and a 
mucin-like protein with a repeated seven amino acid sequence rich in serine (Blaxter and 
Bird, 1997). The N-linked and O-linked glycans of the C. elegans surface coat may even 
take part in adhesion of bacterial pathogens (Page & Johnstone, 2007). 
 Nematodes have the ability to alter the antigenic composition of their surface 
coat. This process, termed surface antigen switching, may occur by molting of the cuticle 
at new developmental stages or in response to environmental cues (Phillip et al., 1980; 
Grenache et al., 1996). During Trichinella spiralis development, each post-embryonic 
stage exhibits different surface antigens. Stage-specific immune responses directed 
against the infective and gut-resident stages allow later stage nematodes to avoid attack, 
but when reinfected by T. spiralis, rats are able to combat infections using previously 
produced antibodies (Bell et al., 1979; Wakelin and Denham, 1983; Appleton and 
McGregor, 1985). Surface antigen changes may even occur within a developmental stage. 
Non-collagen  Gly-X-Y Domain Non-collagen 
91-381 aa   171-178 aa  9-393 aa 
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Upon entering a new host or host tissue, the nematode may alter its surface coat 
composition and properties (Carlow et al., 1987; Proudfoot et al., 1993a,b; Modha et al, 
1999). It is possible that C. elegans may discard contents of its surface coat into its 
surrounding environment, similar to the process observed for T. canis (Blaxter, et al., 
1992; Politz and Phillip, 1992; Politz, personal communication). Surface switching in C. 
elegans can be triggered by means of environmental cues detected by the nematodes’ 
chemosensory system (Grenache et al., 1996; Olsen et al., 2006). Surface coat antigens in 
C. elegans may therefore be studied to understand the mechanism of control and 
expression of surface proteins, given the similarities in anatomy and development of the 
species of the phylum Nematoda.   
The Cuticle Induces an Immune Response 
The nematode surface may be responsible for the provocation of host immune 
responses. Nematode surface antigens have been shown to evoke a type 2 immune 
response in mammalian systems in which hypothesized Pattern Recognition Receptors 
induced IL-4 production (Tawill et al, 2004). Mice exposed to C. elegans antigens 
produced a Th2 response similar to that elicited by antigens of Brugia malayi and other 
parasitic nematodes. Carbohydrates bound to these antigens may be responsible for this 
type of immune response (Tawill et al., 2004). In general, extracellular peptide antigens 
may potentially elicit the production of Th2 cells from naïve CD4 T cells (Janeway et al., 
2005). CD4 cells may differentiate into Th1 or Th2 cells and the factors determining 
differentiation are not completely known (Janeway et al., 2005). In hosts infected by 
Mycobacterium leprae, when macrophages are activated by Th1 cells, little bacteria 
remains and patients typically survive. If CD4 cells differentiate into Th2 cells, however, 
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a humoral response occurs, which is often fatal for a patient (Janeway et al., 2005). Some 
parasitic worms also induce IL-10 production which causes anti-inflammatory cytokine 
production (van der Kleij et al., 2002).  
Toxocara canis and Caenorhabditis elegans 
Toxocara canis (T. canis) is a parasitic canid nematode whose transmission occurs 
via ingestion of the species’ eggs (Center for Disease Control, 2007). Like the dauer stage 
of C. elegans, T. canis infective larvae are developmentally arrested and may live for 
many years in mammalian species other than the definitive canid host. More notably, the 
larvae discharge large quantities of Toxocara excretory/secretory (TES) antigens, which 
are glycoproteins found in the cuticle and surface coat (Gems and Maizels, 1996; Maizels 
et al., 2000). One of the most abundant antigens belongs to the TES-120 family of 
heavily O-glycosylated glycoproteins. cDNAs encoding Tc-muc-1, 2, 3, and 4 have been 
shown to encode TES-120. With the serine/threonine domain of the encoded proteins 
existing as about 72.1% serine/threonine at the N-terminus, this site serves as a location 
for O-glycosylation to occur (Gems and Maizels, 1996). Another distinct domain in TES-
120 is characterized by a six-cysteine (SXC) motif which consists of two 36 amino acid 
sequences each with six cysteines in fixed positions (Gems and Maizels, 1996). Based on 
modeling studies (see Figure 3) these six cysteine residues are believed to form 
intramolecular disulfide bonds (Loukas et al., 2000). 
  When comparing the cDNAs of T. canis and C. elegans, the SXC domain has 
also been found to exist in at least 75 C. elegans genes comprised of about 300 SXC 
domains (Maizels et al., 2000; Emery, 2002). This domain has also been observed in 
other nematode species such as Trichuris muris and Necatur americanus, giving rise to 
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its similar name, NC6, or [Nematode (Cys)6] (Blaxter, 1998; Daub et al., 2000; Gems and 
Maizels, 1996; Maizels et al., 2000). In addition to Tc-muc-1, three other mRNAs for 
apomucins have been found: Tc-muc-2-4, where Tc-muc-2 and Tc-muc-3 are secreted 
mucins (Maizels et al., 2000; Loukas et al., 2000). The information available on C. 
elegans and T. canis SXC sequences was used to design peptides for obtaining anti-
nematomucin antibody probes. 
 
 
 
 
Figure 3. 3D structures of SXC domains. (Top) BgK toxin of the sea anemone Bunodosoma granulifera 
from which the Tc-MUC-1 SXC domain (bottom) was modeled. Disulfide bonds are shown in red and 
conserved residues of T. canis SXC domains are shown in green. Reproduced from Loukas et al. 2000. 
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Figure 4. Alignment of T. canis mucin sequences and F41G3.10 of C. elegans. 
 Emery (2002) aligned the amino acid sequences of the MUC-1 to -4 SXC 
domains in T. canis with the exons of F41G3.10 of C. elegans (see Figure 4). F41G3.10 
was of interest because it maps genetically near srf-6(yj13). When designing anti-peptide 
antibodies, the C1–C2 loop sequences were chosen since they are highly variable and, 
based on the 3D model shown in Figure 3, should be most accessible to antibody binding 
(Emery, 2002; Politz, personal communication).  
Other C. elegans protein sequences with SXC domains were grouped based on the 
distances between the cysteines of the SXC motif, the location of this domain in the gene, 
and whether the SXC domain was “whole” or “split” (Emery, 2002). From this, five 
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families of proteins were created. Synthetic peptides were made for each family and 
contained a peptide sequence unique to that family, as shown in Figure 5.  
Peptides were conjugated separately to keyhole limpet hemocyanin and anti-
peptide antibodies were then made by injection of these conjugates into four rabbits. Two 
rabbits were injected with the peptide for the F41G3.10 family, and the others were 
injected with peptides representing all five of the families. Pre-immune serum and 
antiserum were collected. For this project, only the single peptide antibody was used.  
 
SXC Peptide SXC Family 
1. F41G3.10-5: NH2-VDLTNPSTGVSD-CONH2 3 
2. T05B4.12-3: NH2-TSYAADSSTS-CONH2 5 
3. F35E8.10-1: NH2-PNVAYPRLN-CONH2 2 
4. T05B4.10-2: NH2-GGGGVDAVTN-CONH2 4 
5. Y39G8B.g-1: NH2-GGGIDDPDVD-CONH2 2 
Figure 5. Synthetic peptides representing the amino acid regions unique to the five SXC families (Politz, 
personal communication). 
 
ELISA assays were performed to confirm the presence of antibodies specific for the 
target peptides. Antiserum and pre-immune serum were incubated with the F41G3.10 
peptide and antibody binding was detected using horse-radish-peroxidase (HRP) bound 
secondary antibodies. Antiserum was shown to contain antibodies specific for F41G3.10 
whereas pre-immune serum lacked presence of antibodies (see Figure 6). 
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Figure 6. ELISA of the F41G3.10-5 peptide incubated with pre-immune and antiserum. Results of 
pre-immune serum are shown in pink, antiserum is shown in blue. 
 
Previous projects have examined the expression of cuticle proteins in mixed 
developmental stage protein fractions of wild-type N2 worms. Mutetwa (2007) showed, 
using the single-peptide antiserum, that a 52kDa protein is expressed in cuticle and total 
protein fractions whereas little to no expression was shown in cellular protein fractions. 
This is observed in Figure 7. Figure 8 also determined the preimmune serum to lack 
presence of any anti- F41G3.10 antibody. 
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Figure 7. Mixed developmental stage N2 protein fractions probed with single-peptide antiserum. (From 
left) 02/11/04 cuticle protein; 02/11/04 total protein; 08/13/04 cuticle protein; 08/13/04 total protein; 
08/13/04 cellular protein; Invitrogen SeeBlue® marker. From Mutetwa 2007. 
 
 
Figure 8. Mixed developmental stage N2 protein fractions probed with pre-immune serum. (From left) 
02/11/04 cuticle protein; 02/11/04 total protein; 08/13/04 cuticle protein; 08/13/04 total protein; 08/13/04 
cellular protein; Invitrogen SeeBlue® marker. From Mutetwa 2007. 
 
Surface Mutants of C. elegans 
 
 Various mutations in C. elegans affect cuticle composition and expression. Srf 
mutants are characterized by their altered surface binding of lectin or antibody stains, 
with no change to cuticle morphology (Kramer, 1997). Srf-6(yj13) mutants are 
 15 
characterized by their expression of an L1 surface antigen at later developmental stages 
(Grenache et al., 1996; Kramer, 1997; Olsen et al., 2006). Other srf mutants, such as srf-2 
or srf-3, have cuticle features abrogated by the mutations (Politz et al., 1990; Politz and 
Phillip 1992; Kramer, 1997). 
 Two other notable classes of surface mutants are bah and bus mutants. Bah, or 
biofilm absent head, mutants are resistant to formation of a biofilm on the head by the 
bacterium Yersinia pestis (Darby et al., 2007). When exposed to a different bacterium, 
Microbacterium nematophilum, bus, or bacterially unswollen, mutants do not develop the 
tail swelling at the anal region that occurs in wild-type as a result of infection (Gravato-
Nobre et al., 2005). Studying these surface mutants will allow for comparison of 
nematomucin expression with wild-type expression. 
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PROJECT PURPOSE 
 
Previous projects have examined the expression of proteins within the cuticle of 
C. elegans as a model for mucin expression in T. canis. This project examines the 
differences in glycoprotein expression of the C. elegans cuticle among surface mutant 
strains. Use of a single-peptide antibody directed against the F41G3.10-5 synthetic 
peptide was used to compare N2 wild-type protein expression with various surface 
antigens among surface mutant strains.
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METHODS 
Protein Samples 
Protein samples were prepared by lysis of mixed-stage worms by sonication. This 
lysate became the total protein fraction. Centrifugation separated the cellular and cuticle 
protein fractions. Spinning down the total protein formed the cellular protein fraction, or 
the supernatant, and the cuticle, which was the pellet. Mutant strains used are shown in 
table 1. Two N2 (wild-type) preparations were used, N2_2007 prepared by Mutetwa 
(2007) and N2 (8.13.04), prepared by Chenying Guo (unpublished). 
Table 1. Mutant strains used for comparison to wild-type. 
Strain  Gene Allele 
AT18 srf-6 (yj13) 
DC3 srf-2 (br3) 
DC10 srf-2 (br10) 
DC8 bah-2 (br8) 
DC4 bus-4 (br4) 
DC11 bus-17 (br11) 
DC7 bah-2 (br7) 
DC1 bah-1 (br1) 
 
BCA Protein Concentration Assay 
For each protein fraction, 10ul of the sample was combined with 90ul of acetone 
in an eppendorf tube. The tubes were capped and incubated at -20°C overnight to allow 
for protein precipitation. The following day, the tubes were centrifuged for 10 minutes at 
room temperature in a microcentrifuge at the maximum speed. The supernatant was 
carefully removed with a micropipette and the tubes air dried for one hour uncapped to 
evaporate any remaining acetone. 
 Using the Pierce Micro BCA Protein Assay kit, the working reagent was prepared 
by combining 25 parts Reagent MA, 24 parts Reagent MB, and 1 part Reagent MC. A 
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total volume of working reagent sufficient for all samples to be tested was prepared 
according to the following formula: 
(# of samples + 9 BSA standards) x (# of duplicates) x (1mL/sample) = Total working 
reagent volume. 
0.5mL of the working reagent was added to each unknown sample tube, mixed to 
dissolve the protein pellet, and then transferred to a labeled test tube. An additional 
0.5mL of working reagent was then added in addition to 1.0mL of dH2O for a final 
volume of 2.0ml. In another set of test tubes labeled A-I, BSA standard dilutions were 
made as in table 2. 
Table 2. Dilution series of BSA protein standard for BCA protein concentration assay. 
Tube Diluent- dH2O (mL) BSA (mL)  
Initial conc. of  
2.0 mg/mL 
Final BSA Conc. 
(ug/mL) 
A 1.80 0.20 200 
B 3.60 0.80 of A 40 
C 1.60 1.60 of B 20 
D 1.60 1.60 of C 10 
E 1.60 1.60 of D 5.0 
F 1.60 1.60 of E 2.5 
G 1.92 1.28 of F 1.0 
H 1.60 1.60 of E 0.50 
I 2.00 ----------- 0 
 
1.0mL of each standard was transferred to a new test tube and 1.0mL of working 
reagent added for a final volume of 2.0mL. Standard and sample tubes were incubated at 
60°C for one hour. After incubation the tubes were cooled to room temperature. 
Absorbance values of each sample and standard were then measured at 562nm all within 
ten minutes to minimize change in the color of the reaction. For duplicates, values were 
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averaged, and a standard curve using these averages was generated in Microsoft Excel to 
interpolate sample concentrations. 
 
SDS-PAGE 
Protein samples were pipetted into respective eppendorf tubes so that tubes 
contained ~10ug of protein. However volumes did not exceed 10ul. If less than 10ul was 
pipetted, volumes were brought up to 10ul with dH2O. In another eppendorf tube, 10ul of 
Invitrogen SeeBlue®Plus 2 marker were pipetted. 10ul of Laemmli sample buffer (see 
appendix) was added to each sample and marker tube.  
Tubes were then capped and heated on a boiling water bath for five minutes. After 
boiling, tubes were momentarily centrifuged and loaded into separate lanes on a Bio-Rad 
Tris-HCl Ready Gel® (12% polyacrylamide). 20ul of each sample was loaded into the 
gel. The gel ran for one hour at 160V or 1hr. and 20 minutes at 120V. After the gel ran, 
migration distances of the standards in the marker lane were measured from the top of the 
resolving gel. Some gels were stained with Coomassie Blue to detect total protein. In this 
instance, the gel was placed in a container with staining solution (see appendix) and 
covered to incubate overnight at 4°C on a shaker. 
 The following day, the staining solution was poured off and the gel was soaked in 
destaining solution (see appendix) overnight at 4°C or for ~5 hours at room temperature. 
After destaining, the solution was poured off and the gel was stored in 7% Acetic acid at 
room temperature. An image of the gel on a white light box was taken using a digital 
camera. The camera lens was made level to the plane of the gel so as not to skew the 
image. 
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Western Blot 
 0.5mL eppendorf tubes were labeled (# of tubes = # of protein fractions + one 
marker). 10ul of each sample were pipetted into their respective tubes and 10ul of 
Laemmli buffer aliquotted into each tube for a total volume of 20ul. The tubes were 
boiled for 5 minutes and then spun momentarily in a microcentrifuge. Afterwards, 20ul of 
each sample and marker were then loaded into separate lanes on a Bio-Rad Tris-HCl 
Ready Gel® (12% polyacrylamide). The proteins were separated electrophoretically for 1 
hour at 160V. 
 After electrophoresis, the transfer apparatus was set up, apparatus chamber filled 
with transfer buffer (see appendix), and a Millipore Immobilon P Polyvinylidene  
Fluoride (PVDF) transfer membrane (7.0cm x 8.4cm) prepared for transfer. To prepare 
the membrane, it was first soaked in methanol for 15 seconds, then dH2O for 2 minutes, 
and lastly in transfer buffer for 5+ minutes. Fiber and sponge pads were also soaked in 
transfer buffer. A blotting sandwich was prepared using the cassette, a sponge pad, fiber 
pad, gel, prepared membrane, fiber pad, and sponge pad. The membrane was also cut to 
fit the size of the gel. This arrangement is shown in Figure 9. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Cassette setup for transfer apparatus. 
 
- Fiber Pad 
- Whatman Paper  
- Membrane 
- Gel 
- Whatman Paper 
- Fiber Pad 
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A stir bar was place in the chamber to equilibrate the temperature of the buffer 
throughout its volume. The transfer cassette was placed into the chamber and the transfer 
was performed for 1 hour at 120mA. The apparatus was placed in ice on a stir plate to 
maintain the temperature of the buffer. 
 After the transfer ran, the membrane was covered in 30mL blocking buffer (see 
appendix) overnight at 4°C on a shaker. The following day, the old blocking buffer was 
poured off and 30mL of fresh blocking buffer was poured onto the membrane along with 
100ul primary antibody. This incubated overnight on a shaker at 4°C. The following day 
the primary antibody/blocking buffer solution was removed and stored in a 50mL conical 
tube at 4°C. The membrane was then washed with 50mL blocking buffer for 10 minutes 
on a shaker at room temperature (3x).  
Blocking buffer was then poured off and 20mL fresh blocking buffer and 20ul 
secondary antibody (Sigma #F9259, goat anti-mouse IgM horseradish peroxidase) were 
poured onto the membrane and allowed to incubate on the shaker at room temperature. 
The buffer solution was poured off and the membrane was then washed again with 50mL 
blocking buffer for 10 minutes on a shaker at room temperature (3x). Color of the 
membrane was developed using the Bio-Rad Opti-4CN kit until color was satisfactory. 
One part Opti 4CN diluent and nine parts dH2O for every 0.25cm2 of membrane were 
combined. 0.2mL of the substrate (per 10mL of diluent) were then added to the diluent 
mixture, mixed, and poured onto the membrane. When the color of development was 
satisfactory, development was stopped by placing the membrane in dH2O for 2 minutes. 
Membranes were wrapped in a paper towel, stored out of light, and allowed to dry 
overnight. For long-term storage, membranes were placed in aluminum foil. 
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Spot Test 
 While a Millipore Immobilon P Polyvinylidene Fluoride (PVDF) transfer 
membrane was prepared, 10ul of each sample was pipetted into an eppendorf tube and 
boiled for five minutes. The membrane was then spotted with 10ul of each sample and 
sample spots allowed to dry. The membrane was then blocked with 30mL of blocking 
buffer for one hour at room temperature on a shaker. The membrane was cut into the 
appropriate number of divisions. For example, if two sets of tests were being run on the 
same membrane, the membrane was cut in half.  
 For a negative control and test sample, the membrane was cut in half, and one half 
incubated at room temperature for one hour in 20 ml blocking buffer, and the other half 
incubated at room temperature with 20mL blocking buffer and 66ul primary antibody, 
both on a shaker. The amount of primary antibody and blocking buffer was determined 
from the primary antibody/blocking buffer ratio in the western blot procedure (100ul 
primary antibody: 30mL blocking buffer), where 20mL blocking buffer was needed to 
cover the membrane sufficiently for incubation. The primary antibody solution was 
stored in a conical tube, and membranes were washed three times on a shaker for 10 
minutes each with fresh 15mL blocking buffer each time. Both membranes were then 
incubated at room temperature for one hour with 30ul secondary antibody and 15mL 
blocking buffer on a shaker. Membranes were then washed again in the same manner 
three times.  
 Development of the membrane color occurred by combining one part Opti 4CN 
diluent and nine parts dH2O for every 0.25cm2 of membrane. 0.2mL of the substrate (per 
10mL of diluent) were then added to the diluent mixture, mixed, and poured onto the 
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membrane. When the color of development was satisfactory, development was stopped 
by placing the membrane in dH2O for 2 minutes. Membranes were wrapped in a paper 
towel, stored out of light, and allowed to dry overnight. For long-term storage, 
membranes were placed in aluminum foil.
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RESULTS 
Protein Concentrations 
Concentrations of protein fractions prepared by Mutetwa (2007) are shown in 
table 3. These were determined by Mutetwa by a BCA assay. 
Table 3. Concentrations of mutant and wild-type protein fractions.  
(Mutetwa, personal communication). 
Genotype  
Protein 
Sample 
Concentration 
(ug/ul) 
Wild type Total 3.833 
 Cellular 7.684 
 Cuticle 7.061 
srf-2(br3) Total 2.714 
 Cellular 4.805 
 Cuticle 0.753 
srf-2(br10) Total 1.565 
 Cellular 1.610 
 Cuticle 0.402 
 Total 5.887 
 Cellular 1.105 
 Cuticle ----------------- 
srf-6(yj13) Total 5.047 
 Cellular 1.327 
 Cuticle 1.258 
bah-2(br8) Total 6.055 
 Cellular 5.347 
 Cuticle 2.761 
bus-4(br4) Total 3.043 
 Cellular 8.288 
 Cuticle 1.049 
bus-17 
(br11) Total 2.313 
 Cellular 1.926 
 Cuticle 0.076 
bah-2(br7) Total 2.131 
 Cellular 5.480 
 Cuticle 3.861 
bah-1(br1) Total 0.225 
 Cellular 0.639 
 Cuticle 0.367 
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Protein concentrations determined by a BCA assay for the N2 (8.13.04), N2_2007, bah-
1(br1), srf-2(br3), and srf-6(yj13) protein fractions are shown in table 4.  
 
Table 4. Concentrations of mutant and wild-type protein fractions. 
Sample 
N2 (8.13.04) 
(ug/ul) 
N2_2007 
(ug/ul) 
srf-6(yj13) 
(ug/ul) 
bah-1(br1) 
(ug/ul) 
srf-2(br3) 
(ug/ul) 
Total 7.140993789 0.21372549 12.19068323 0.238562092 N/A 
Cellular 5.234161491 1.056862745 12.84161491 2.283660131 1.122875817 
Cuticle 9.57826087 0.974509804 4.636645963 0.187581699 0.669934641 
 
Viability of Protein Samples  
Protein extracts from mixed stages of each strain were loaded in separate SDS-
PAGE gel lanes. Sample viability and degradation were inferred from the intensity of the 
stainings. The intensities of the lanes in Figure 10 suggested the presence of similar 
sample concentrations among the bah-1(br1), srf-2(br3), and N2_2007 protein fractions, 
except for the cuticle fractions, which appeared to contain less protein than other 
fractions. 
 
Figure 10. Comparison of protein concentrations by coomassie staining. Lane 1, bah-1(br1) Total, 2.4ug; 
Lane 2, bah-1(br1) Cellular, 10.0ug; Lane 3, bah-1(br1) Cuticle, 1.9ug; Lane 4, N2_2007 Total, 2.1ug; 
Lane 5, N2_2007 Cellular, 10.0ug; Lane 6, N2_2007  Cuticle, 9.7ug; Lane 7, srf-2(br3) Total, 27.1ug; Lane 
8, srf-2(br3) Cellular, 10.0ug; Lane 9, srf-2(br3) Cuticle, 6.7ug; Lane 10, Invitrogen SeeBlue® marker. 
 
Figures 11 and 12 examine the viability of bus-4(br4), bus-17(br11), srf-6(yj13), bah-
2(br7), srf-2(br10), and bah-2(br8) protein fractions. No marker is shown in Figures 11 
and 12. The intensity of the stain for the bus-17(br11) cuticle fraction was weakest of all 
    
   (kDa) 
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fractions from bus-4(br4), bus-17(br11), and srf-6(yj13). The intensity of the stain of the 
srf-6(yj13) cuticle fraction was more visible than the bus-17(br11) cuticle; however it 
was weaker than the other fractions in the gel (Figure 11). The cuticle fractions of srf-
2(br10) and bah-2(br7) both stained the weakest compared to the total and cellular 
fractions of the two strains. The staining patterns of the SDS-PAGE gels demonstrate that 
the proteins are not grossly degraded, although this conclusion could not be reached 
about the cuticle fractions, in which bands were poorly detected.   
 
Figure 11. Comparison of protein concentrations by coomassie staining. Lane 1, bus-4(br4) Total, 30.4ug; 
Lane 2, bus-4(br4) Cellular, 82.9ug; Lane 3, bus-4(br4) Cuticle, 10.5ug; Lane 4, bus-17(br11) Total, 
23.1ug; Lane 5, bus-17(br11) Cuticle, 0.76ug; Lane 6, bus-17(br11) Cellular, 19.3ug; Lane 7- srf-6(yj13) 
Total, 10.0ug; Lane 8, srf-6(yj13) Cellular, 10.0ug; Lane 9, srf-6(yj13) Cuticle, 4.6ug. 
1       2       3         4        5      6        7       8          9       
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Figure 12. Comparison of protein concentrations by coomassie staining. Lane 1, bah-2(br7) Total, 21.3ug; 
Lane 2, bah-2(br7) Cellular, 54.8ug; Lane 3, bah-2(br7) Cuticle, 38.6ug; Lane 4, srf-2(br10) Cuticle, 
4.02ug; Lane 5, srf-2(br10) Cellular, 16.1ug; Lane 6, srf-2(br10) Total, 15.7ug; Lane 7, bah-2(br8) Total, 
60.6ug; Lane 8, bah-2(br8) Cellular, 53.5ug; Lane 9, bah-2(br8) Cuticle, 27.6ug. 
 
Analysis of Protein Fractions 
The single-peptide antibody directed against the unique sequence of the synthetic 
F41G3.10-5 peptide was used to probe the protein fractions to determine the presence of 
proteins containing this antigen. In the experiment shown in Figure 13, srf-6(yj13) and 
the two N2 preparations were compared. A band at ~52 kDa was present in most of the 
fractions; however, it was most prominent in the total and cuticle fractions of the N2 
(8.13.04) preparation. The 52 kDa band was not detected in the N2_2007 total protein 
extract (Figure 13, lane 6). More notably, the 52 kDa band was present in the srf-6(yj13) 
total and cellular fractions, but was not detected in the srf-6(yj13) cuticle fraction. 
    1     2       3         4        5      6        7       8       9    
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Figure 13. Western blot using the single-peptide antibody directed against the F41G3.10 protein.  
Lane 1, Srf-6(yj13) Cuticle, 10.0ug; Lane 2, Srf-6(yj13) Cellular, 10.0ug; Lane 3, Srf-6(yj13) Total, 10.0ug; 
Lane 4, N2_2007 Cuticle, 9.7ug; Lane 5, N2_2007 Cellular, 10.0ug; Lane 6, N2_2007 Total, 2.1ug; Lane 
7, N2 (8.13.04) Total, 10.0ug; Lane 8, N2 (8.13.04) Cellular, 10.0ug; Lane 9, N2 (8.13.04) Cuticle, 10.0ug; 
Lane 10, Invitrogen SeeBlue® marker.  
 
The experiment shown in Figure 14 compared the N2 (8.13.04) preparations with those 
of srf-6(yj13) and srf-2(br10). Prominent presence of an ~52 kDa band was seen in the 
total and cuticle protein fractions of the N2 (8.13.04) sample. A less prominent band was 
also seen in the cellular N2 (8.13.04) fraction at ~52 kDa. In srf-2(br10) and srf-6(yj13) 
fractions, protein bands were not very visible. 
 
Figure 14. Western blot using the single-peptide antibody directed against the F41G3.10 protein.  
Lane 1, Invitrogen SeeBlue® marker; Lane 2, srf-2(br10) Cuticle, 4.02ug; Lane3, srf-2(br10) Cellular, 
16.1ug; Lane 4, srf-2(br10) Total, 15.7ug; Lane 5, Srf-6(yj13) Cuticle, 10.0ug; Lane 6, Srf-6(yj13) Cellular, 
10.0ug; Lane 7, Srf-6(yj13) Total, 10.0ug; Lane 8, N2 (8.13.04) Cuticle, 10.0ug; Lane 9, N2 (8.13.04) 
Cellular, 10.0ug; Lane 10, N2 (8.13.04) Total, 10.0ug.  
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N2_2007 fractions were then compared to bah-1(br1) and srf-2(br3) protein. (Fig. 15). 
Here, prominent bands at ~52kDa appeared in the total and cellular fractions of srf-
2(br3), bah-1(br1), and N2_2007. The N2_2007 total fraction, bah-1(br1) cuticle 
fraction, and srf-2(br3) cuticle fraction, however, did not reveal the 52kDa band.  
Additionally, a band at 36 kDa appeared in both the bah-1(br1) cellular and cuticle 
fractions as shown in Figure 15. 
 
   
Figure 15. Western blot using the single-peptide antibody directed against the F41G3.10 protein.  
Lane 1, Invitrogen SeeBlue® marker; Lane 2, srf-2(br3) Cuticle, 6.7ug; Lane 3, srf-2(br3) Cellular, 10.0ug; 
Lane 4, srf-2(br3) Total, 27.1ug; Lane 5, bah-1(br1) Cuticle, 1.9ug; Lane 6, bah-1(br1) Cellular, 10.0ug; 
Lane 7, bah-1(br1) Total, 2.4ug; Lane 8, N2_2007 Total, 2.1ug; Lane 9, N2_2007 Cellular, 10.0ug; Lane 
10, N2_2007 Cuticle, 9.7ug.  
 
For bah-2(br7) and bus-4(br4), the single-peptide antibody probe was used to 
compare expression of the antigenic protein in these two strains to N2_2007. Bands 
showed less prominently than in other blots (see Figure 16). Visible bands were observed 
in cellular fractions of each strain but not in other fractions. 
Use of the N2 (8.13.04) preparation was resumed when compared to bah-2(br8) 
and bus-17(br11). However, when these blots were developed, only weak bands in the 
total and cuticle fractions of the N2 (8.13.04) sample were present. No other fractions 
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displayed presence of any protein bands. This was performed twice to examine this 
result. Figures 17a and 17b show the results of these two blots.  
 
 
 
Figure 16. Western blot using the single-peptide antibody directed against the F41G3.10 protein.  
Lane 1, N2_2007 Total, 2.1ug; Lane 2, N2_2007 Cellular, 10.0ug; Lane 3, N2_2007 Cuticle, 9.7ug; Lane 
4, bus-4(br4) Total, 30.4ug; Lane 5, bus-4(br4) Cellular, 82.9ug; Lane 6, bus-4(br4) Cuticle, 10.5ug; Lane 
7, bah-2(br7) Total, 21.3ug; Lane 8, bah-2(br7) Cellular, 54.8ug; Lane 9, bah-2(br7) Cuticle, 38.6ug; Lane 
10, Invitrogen SeeBlue® marker. 
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(17a)  
(17b)  
Figure 17. Western blot using the single-peptide antibody directed against the F41G3.10 protein.  
(Same for #a and #b): Lane 1, N2 (8.13.04) Total, 10.0ug; Lane 2, N2 (8.13.04) Cellular, 10.0ug; Lane 3, 
N2 (8.13.04) Cuticle, 10.0ug; Lane 4, bah-2(br8) Total, 60.6ug; Lane 5, bah-2(br8) Cellular, 53.5ug; Lane 
6, bah-2(br8) Cuticle, 27.6ug; Lane 7, bus-17(br11) Total, 23.1ug; Lane 8, bus-17(br11) Cellular, 19.3ug; 
Lane 9, bus-17(br11) Cuticle, 0.76ug; Lane 10, Invitrogen SeeBlue® marker.  
 
Integrity of Secondary Antibody 
 The activity of the secondary antibody used in the western blot procedure for the 
Figure 16 and Figure 17 blots was tested by a spot test. The concentration of the 
secondary antibody was tested in Figure 18, where the concentration was increased two-
fold and three-fold. N2 (8.13.04) preparations were used, and after color development, no 
color appeared when the membrane dried. 
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Figure 18. Spot test concentration assay. From left- three-fold, two-fold, and normal concentration of 
secondary antibody. For each membrane strip: Top- N2 (8.13.04) total, 10.0ug; Middle- N2 (8.13.04) 
Cellular, 10.0ug; Bottom- N2 (8.13.04) Cuticle, 10.0ug. 
 
The test was repeated with a control in which primary antibody was not added. Once 
again after color development, while the membrane was still wet, both the negative 
control and membrane developed with primary and secondary antibodies showed similar 
color as shown in Figure 19. 
 
Figure 19. Spot test of secondary antibody. Left- negative control. Right- both primary and secondary 
antibody used. For each membrane strip: Top- N2 (8.13.04) total, 10.0ug; Middle- N2 (8.13.04) Cellular, 
10.0ug; Bottom- N2 (8.13.04) Cuticle, 10.0ug.
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DISCUSSION 
 
 
Surface mutant protein samples were examined by SDS-PAGE and Coomassie 
staining to assess the viability of the samples. Due to an error in calculating protein 
concentrations, the protein amounts loaded for some mutant protein fractions were 
incorrect. This resulted in more than 10.0ug being used for some protein fractions in 
SDS-PAGE and western blot experiments. Conversely, less than 10ug of some mutant 
protein extracts was loaded because of low sample concentration.  Observation of the 
protein concentrations in Tables 3 and 4 also indicates that some protein fractions 
contained very small protein amounts. Because of this, conclusions regarding protein 
viability and concentration of such samples are inconclusive. For the SDS-PAGE gels in 
Figures 11 and 12, the absence of the marker did not allow for any analysis of band sizes. 
Ultimately, the sample proteins were deemed undegraded since protein bands were 
visible in most samples, which made them suitable candidates for use in western blotting 
analysis. Weak band staining for cuticle fractions may be attributable to the collagen 
within these fractions not staining well with coomassie blue.   
By using the single-peptide antibody, blots revealed antibodies bound to a specific 
52 kDa antigen. The benefit of this method is that the antibody has specificity for the 
amino acid sequence specific to the protein as opposed to carbohydrates like lectin stains. 
For example, with a lectin stain, binding to multiple bands in cellular protein extracts is 
commonly observed. Western blotting procedures using this antibody were performed to 
compare the protein expression in surface mutants to protein expression in the wild-type 
N2 strain. The specificity of this antibody has revealed somewhat remarkable results. 
Firstly, some protein fractions in bah-1(br1), srf-2(br3), bus-4(br4), bah-2(br7), and srf-
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6(yj13) displayed the presence of the F41G3.10 target peptide as demonstrated by the 
binding of the antibody to a protein at ~52 kDa similar to that of the wild-type N2 strain 
(Figures 13, 15 and 16).  However, the ~52 kDa antigen was detected very weakly in srf-
6(yj13) and srf-2(br10) extracts, in spite of the fact that protein amounts approximately 
equivalent to the positive controls were loaded (Figures 13 and 14).  The other srf-2 allele 
tested, br3, showed a more intense ~52 kDa band than did srf-2(br10).  These two alleles 
should be retested side-by-side and compared to other available srf-2 alleles to determine 
if this difference is reproducible and extends to other mutant proteins.  The bah-1(br1) 
strain also exhibited binding of the single peptide antibody to a protein band at 36 kDa in 
the cuticle and cellular fractions (Figure 15). This suggests that the expected 52 kDa 
protein may undergo post-translational processing such as proteolysis possibly due to 
defects in glycosylation, which normally helps to protect against this action. This would 
account for protein bands of two different sizes.  
It was also noticed that in the wild-type N2 strain, a faint band appeared in the 
cellular fraction at 52 kDa much like the total and cuticle protein fractions (Figure 13). 
The predicted size of the F41G3.10 protein from its sequence is about 50 kDa (Fig. 4). 
Bands in the total and cuticle fractions are expected since the protein is secreted into the 
cuticle, and the total fraction also contains the cuticle fraction. An obvious explanation 
exists as a possibility for presence of the same protein in the cellular fraction. Protein 
processing occurs within the cell itself, not at the cuticle level of the worm. Therefore, it 
should be expected to see a protein band in the cellular fraction reflecting the presence of 
the protein en route to being secreted or having just been translated. Another reason why 
the 52 kDa band is observed in the cellular fraction could be contamination from the 
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cuticle fraction during preparation, or vice-versa. In addition, the protein being observed 
may be the underglycosylated form since glycosylation may prevent bind of the antibody 
to the target sequence. 
There are various directions in which this project may proceed in the future. 
Firstly, the integrity of the later western blotting experiments was compromised, possibly 
a result of the secondary antibody. Blots comparing bus-4(br4), bah-2(br7), bah-2(br8), 
bus-17(br11) to N2 did not develop well (Figure17), producing very faint bands for even 
the N2 control protein fractions when probed with the F41G3.10-5 single-peptide 
antibody. Comparison of these strains should be repeated for an accurate result. Mutetwa 
(2007) suggests examining the expression of protein products from all known surface 
mutants to compare glycosylation. In particular, bus-4 and bus-17 encode a galactosyl 
transferase which would affect glycosylation (Hodgkin, personal communication). 
Moreover, since this project used mixed developmental stages when analyzing and 
comparing strains, differences in protein expression during development may have gone 
unnoticed. It is possible that the same protein is expressed throughout development yet is 
glycosylated in a different manner at each molt. Another possibility is an entirely 
different protein is expressed at each molt in the cuticle (Politz, personal 
communication). Various N2 stage worms may be compared for differences in 
development this way, or even use of mutant strains may be performed. Additionally, 
other mutants may be compared to N2 to determine similar protein expression. 
 
  
 
 36 
BIBLIOGRAPHY 
Appleton, J.A., and McGregor, D.D. (1985) Life-phase specific induction and expression 
 of rapid expulsion in rats suckling Trichinella spiralis-infected dams.  
 Immunology 55: 225-232. 
 
Blaxter, M.L. (1998) Caenorhabditis elegans is a nematode. Science 282: 2041-2046. 
 
Blaxter, M.L., Page, A.P., Rudin, W., and Maizels, R.M. (1992). Nematode surface coats: 
 Actively evading immunity. Paristology Today 8: 243-247. 
 
Blaxter, M. and Bird, D. (1997). Parasitic nematodes. Chapter 30 in the electronic version 
 of C. elegans II, Riddle, D.L., Blumenthal, T., Meyer, B.J., & Priess, J.R.New York: 
 Cold Spring Harbor Laboratory Press.  
 
Carlow, C.K.S.m Perrone, J., Spielman, A., and Phillip, M. (1987) A developmentally 
 regulated surface epitope expressed by the infective larva of Brugia malayi which  
 is rapidly lost after infection. UCLA Symposium Molecular Cell Biology 60: 301-
 310. 
 
Center for Disease Control (2007) Toxocariasis Fact Sheet. Retrieved January 5, 2008, 
 from http://www.cdc.gov/NCIDOD/DPD/parasites/toxocara/factsht_toxocara.htm 
 
Darby, C., Chakraborti, A., Politz, S.M., Daniels, C.C., Tan, L., and Drace, K. (2007) 
 Caenorhabditis elegans mutants resistant to attachment of Yersinia biofilms. 
 Genetics 176: 221-230 
 
Daub, J., Loukas, A., Pritchard, D., Blaxter, M.L. (2000) A survey of genes expressed in 
 adults of the human hookworm Necator americanus. Parisitology 120: 171-184. 
 
Edwards, M.K. and Wood, W.B. (1983). Location of specific messenger RNAs in  
 Caenorhabditis elegans by cytological hybridization. Developmental Biology 97: 
 375-390 
 
Emery, A.M., (2002). Computational analysis of genetic sequences displaying a specific 
 six-cysteine pattern. Masters Thesis, Worcester Polytechnic Institute. 
 
Gems, D., and Maizels, R.A. (1996) An abundantly expressed mucin-like protein from 
 Toxocara canis infective larvae: The precursor of the larval surface coat  
 glycoproteins. Proceedings of the National Academy of Sciences USA 93:  
 1665-1670. 
 
Gravato-Nobre, M.J., Nicholas, H.R., Nijland, R., O’Rourke, D., Whittington, D.E., 
 Yook, K.J., and Hodgkin, J. (2005) Multiple genes affect sensitivity of 
 Caenorhabditis elegans to the bacterial pathogen Microbacterium nematophilum. 
 Genetics 171: 1033-1045 
 
 
 
 
 37 
Grenache, D. G., Caldicott, I., Albert, P. S., Riddle, D. L., and Politz, S. M. (1996).  
 Environmental induction and genetic control of surface antigen switching in the 
 nematode Caenorhabditis elegans. Proceedings of the National Academy of Sciences 
 USA, 93, 12388-12393. 
 
Janeway, C.A., Schlomchik, M.J., Travers, P., and Walport, M. (2005). Immunobiology: 
 The immune system in health and disease (6th edition). New York: Garland Science 
 Publishing. 
 
Kramer, J.M. (1997). Extracellular Matrix. Chapter 17 in the electronic version of C . 
 elegans II, Riddle, D.L., Blumenthal, T., Meyer, B.J., & Priess, J.R.New York: Cold 
 Spring Harbor Laboratory Press. 
 
Loukas, A., Hintz, M., Linder, D., Mullin, N.P., Parkinson, J., Tetteh, K.K., and Maizels, 
 R.M. (2000) A family of secreted mucins from the parasitic nematode Toxocara 
 canis bears diverse mucin domains but shares similar flanking six-cysteine repeat 
 motifs. Journal of Biological Chemistry 275: 39600-39607. 
 
Maizels, R.M., Tetteh, K.K., Loukas, A. (2000) Toxocara canis: Genes expressed by the 
 arrested infective larval stage of a parasitic nematode. International Journal for 
 Parisitology 30: 495-508. 
 
Miguel, E., and Kremer, M. (2004). Worms: Identifying impacts on education and health 
 in the presence of treatment externalities. Econometrica 72: 159-217. 
 
Modha, J., Roberts, M.C., Robertson, W.M., Sweetman, G., Powell, K.A., Kennedy, 
 M.W., and Kusel, J.R. (1999) The surface coat of infective larvae of Trichinella 
 spiralis. Parisitology 118: 509-522. 
 
Mutetwa, B. (2007) Nematomucin antigen expression identification using anti-peptide 
 antibodies. Major Qualifying Project, Worcester Polytechnic Institute 
 
Olsen, D.P., Phu, D., Libby, L.J., Cormier, J.A., Montez, K.M., Ryder, E.F., Politz, S.M. 
 (2006) Chemosensory control of surface antigen switching in the nematode 
 Caenorhabditis elegans. Genes, Brain and Behavior 6: 240-252. 
 
Page, A.P., and Johnstone, I.L. (2007) The cuticle. WormBook, ed. The C. elegans
 Research Community, WormBook, doi/10.1895/ wormbook.1.138.1, 
 Retrieved from http://www.wormbook.org. 
 
Peixoto, C.A., Kramer, J.M., de Souza, W. (1997) Caenorhabditis elegans cuticle: A 
 description of new elements of the fibrous layer. The Journal of Parisitology 83: 
 368-372. 
 
Phillip, M., Parkhouse, R.M.E., and Ogilvie, B.M. (1980) Changing proteins on the 
 surface of a parasitic nematode. Nature 287: 538-540. 
 
 
 38 
Politz, S.M., Phillip, M., Estevez, M., O’Brien, P.J., Chin, K.J. (1990) Genes that can be 
 mutated to unmask hidden antigenic determinants in the cuticle of the nematode 
 Caenorhabditis elegans. Proceedings of the National Academy of Sciences 87:  
 2901-2905. 
 
Politz, S.M., and Phillip, M. (1992) Caenorhabditis elegans as a model for  
 parasitic nematodes: A focus on the cuticle. Parasitology Today 8: 6-12. 
 
Proudfoot, L. Kusel, J.R., Smith, H.V., Hamett, W. Worms, M.J., and Kennedy, M.W. 
 (1993a) Rapid changes in the surface of parasitic nematodes during transition 
 from pre- to post-parasitic forms. Parasitology 107: 107-117. 
 
Proudfoot, L. Kusel, J.R., Smith, and Kennedy, M.W. (1993b) External stimuli and 
 intracellular signaling in the modification of the nematode surface during 
 transition to the mammalian host environment.  Parasitology 107: 559-566. 
 
Riddle, D.L., and Albert, P.S. (1997). Genetic and environmental regulation of dauer 
 larva development. Chapter 26 in the electronic Version of C. elegans II, Riddle, 
 D.L., Blumenthal, T., Meyer, B.J., & Priess, J.R.New York: Cold Spring Harbor 
 Laboratory Press. 
 
Riddle, D.L., Blumenthal, T., Meyer, B.J., & Priess, J.R. (1997). Introduction to C. elegans. 
 Chapter 1 in the electronic Version of C. elegans II, Riddle, D.L., Blumenthal, T., 
 Meyer, B.J., & Priess, J.R. New York: Cold Spring Harbor Laboratory Press. 
 
Tawill, S., Le Goff, L. Ali, F., Blaxter, M., Allen, J.E. (2004) Both free-living and parasitic 
 nematodes induce a characteristic Th2 response that is dependent on the presence 
 of intact glycans. Infection and Immunity 72: 398-407. 
 
Van der Kleij, D., Latz, E., Brouwers, J.F., Kruize, Y.C., Schmitz, M., Kurt-Jones, E.A., 
 Espevik, T., de Jong, E.C., Kapsenberg, M.L., Golenbock, D.T., Tielens, A.G., and 
 Yazdanbakhsh, M. (2002) A novel host-parasite lipid cross-talk. Schistosomal 
 lyso-phosphatidylserine activates toll-like receptor 2 and affects immune 
 polarization. Journal of Biological Chemistry 277: 48122-48129. 
 
Varki, A., Cummings, R., Esko, J., Freeze, H., Hart, G., Marth, J.,  (1999) Essentials of 
 Glycobiology. Cold Spring Harbor: Cold Spring Harbor Press. 
 
Wakelin, D., and Denhanm, D.E. (1983) The immune response, in Trichinella and 
 Trichinosis ed. W.C. Campbell, W.C. Plenum Press, New York, pp. 489-511. 
 
 39 
APPENDIX 
 
Solutions 
 
Blocking Buffer-  
 
0.025M Tris-Base (pH adjusted to 7.5 with HCl), 0.15M NaCl, 1% BSA Fraction V, 
0.1mM PMSF (5mM in EtOH from stock), 2mM EDTA (0.5M stock diNa⋅EDTA, pH 
8.0). Sterile filter (0.45um pore) and store at 4°C. 
 
Destaining Solution- 
 
50% Methanol, 7% Acetic Acid 
 
Laemmli Sample Buffer- 
 
950ul Laemmli Sample Buffer, 50ul β-ME, store at 4°C. 
 
Running Buffer- 
  
Final concentrations: 25mM Tris-Base, 192mM Glycine (from solid salt), 0.1% SDS  
 
Staining Solution- 
  
0.1% Sigma-Aldrich EZBlue Coomassie Brilliant Blue G1041, 50% Methanol, 7% Acetic 
Acid  
 
Transfer Buffer-  
 
Final concentrations: 25mM Tris-Base, 192mM Glycine (from solid salt), 20% v/v 
Methanol, 0.025% SDS, resulting pH of 8.3. Store at 4°C. 
